Literature DB >> 12136239

Sequence polymorphism at the human apolipoprotein AII gene ( APOA2): unexpected deficit of variation in an African-American sample.

Stephanie M Fullerton1, Andrew G Clark, Kenneth M Weiss, Scott L Taylor, Jari H Stengård, Veikko Salomaa, Eric Boerwinkle, Deborah A Nickerson.   

Abstract

A 3.3-kb region, encompassing the APOA2 gene and 2 kb of 5' and 3' flanking DNA, was re-sequenced in a "core" sample of 24 individuals, sampled without regard to the health from each of three populations: African-Americans from Jackson (Miss., USA), Europeans from North Karelia (Finland), and non-Hispanic European-Americans from Rochester, (Minn., USA). Fifteen variable sites were identified (14 SNPs and one multi-allelic microsatellite, all silent), and these sites segregated as 18 sequence haplotypes (or nine, if SNPs only are considered). The haplotype distribution in the core African-American sample was unusual, with a deficit of particular haplotypes compared with those found in the other two samples, and a significantly (P<0.05) low level of nucleotide diversity relative to patterns of polymorphism and divergence at other human loci. Six of the 14 SNPs, whose variation captured the haplotype structure of the core data, were then genotyped by oligonucleotide ligation assay in an additional 2183 individuals from the same three populations (n=843, n=452, and n=888, respectively). All six sites varied in each of the larger "epidemiological" samples, and together, they defined 19 SNP haplotypes, seven with relative frequencies greater than 1% in the total sample; all of these common haplotypes had been identified earlier in the core re-sequencing survey. Here also, the African-American sample showed significantly lower SNP heterozygosity and haplotype diversity than the other two samples. The deficit of polymorphism is consistent with a population-specific non-neutral increase in the relative frequency of several haplotypes in Jackson.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12136239     DOI: 10.1007/s00439-002-0763-x

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  7 in total

1.  The effects of scale: variation in the APOA1/C3/A4/A5 gene cluster.

Authors:  Stephanie M Fullerton; Anne V Buchanan; Vibhor A Sonpar; Scott L Taylor; Joshua D Smith; Christopher S Carlson; Veikko Salomaa; Jari H Stengård; Eric Boerwinkle; Andrew G Clark; Deborah A Nickerson; Kenneth M Weiss
Journal:  Hum Genet       Date:  2004-04-24       Impact factor: 4.132

2.  Genomic regions exhibiting positive selection identified from dense genotype data.

Authors:  Christopher S Carlson; Daryl J Thomas; Michael A Eberle; Johanna E Swanson; Robert J Livingston; Mark J Rieder; Deborah A Nickerson
Journal:  Genome Res       Date:  2005-11       Impact factor: 9.043

3.  APOA2 -256T>C polymorphism interacts with saturated fatty acids intake to affect anthropometric and hormonal variables in type 2 diabetic patients.

Authors:  Marjan Ghane Basiri; Gity Sotoudeh; Ehsan Alvandi; Mahmood Djalali; Mohammad Reza Eshraghian; Neda Noorshahi; Fariba Koohdani
Journal:  Genes Nutr       Date:  2015-04-23       Impact factor: 5.523

4.  Human F7 sequence is split into three deep clades that are related to FVII plasma levels.

Authors:  Maria Sabater-Lleal; José Manuel Soria; Jaume Bertranpetit; Laura Almasy; John Blangero; Jordi Fontcuberta; Francesc Calafell
Journal:  Hum Genet       Date:  2005-11-16       Impact factor: 4.132

5.  Genetic variation and pharmacogenomics: concepts, facts, and challenges.

Authors:  Margret R Hoehe; Thomas Kroslak
Journal:  Dialogues Clin Neurosci       Date:  2004-03       Impact factor: 5.986

6.  APOA2 Polymorphism in Relation to Obesity and Lipid Metabolism.

Authors:  Moushira Erfan Zaki; Khalda Sayed Amr; Mohamed Abdel-Hamid
Journal:  Cholesterol       Date:  2013-12-09

7.  Evaluating the association of APOA2 polymorphism with insulin resistance in adolescents.

Authors:  Moushira Erfan Zaki; Khalda Sayed Amr; Mohamed Abdel-Hamid
Journal:  Meta Gene       Date:  2014-05-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.